Skip to main content
Year archive

Tego Science, Inc. — 2024 filings

All 20 regulatory filings released by Tego Science, Inc. (191420) in 2024, sourced directly from the official regulator.

20 Filings
2024 Period
2024 filings (20)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2024-12-12 Korean
분기보고서 (2024.09)
Interim / Quarterly Report 9M 2024
2024-11-14 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2024-10-31 Korean
반기보고서 (2024.06)
Interim / Quarterly Report H1 2024
2024-08-14 Korean
투자판단관련주요경영사항(임상시험계획승인신청등결정) (코입술주름 개선 세포치료제 TPX121 제1상 임상시험계획 승인 )
Regulatory Filings
2024-07-26 Korean
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (코입술주름 개선 세포치료제 TPX121 제1상 임상시험계획 승인 )
Regulatory Filings
2024-07-26 Korean
기타시장안내 (업종변경 안내)
Regulatory Filings
2024-06-28 Korean
주요사항보고서(유형자산양도결정)
Capital/Financing Update
2024-05-29 Korean
투자판단관련주요경영사항 (주름개선 세포치료제 로스미르의 식품의약품안전처 허가조건 변경 승인)
Regulatory Filings
2024-05-21 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Q1 2024
2024-05-14 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2024-03-27 Korean
[기재정정]사업보고서 (2023.12)
Annual Report FY 2023
2024-03-27 Korean
감사보고서제출
Audit Report / Information FY 2023
2024-03-19 Korean
사업보고서 (2023.12)
Annual Report FY 2023
2024-03-19 Korean
[기재정정]감사보고서제출
Audit Report / Information FY 2023
2024-03-19 Korean
주주총회소집결의
AGM Information
2024-03-08 Korean
주주총회집중일개최사유신고
AGM Information
2024-03-08 Korean
[기재정정]주주총회집중일개최사유신고
AGM Information
2024-03-08 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2024-03-08 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2023
2024-01-30 Korean